Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
53.3%
operating margin TTM
42.4%
revenue TTM
52.19 Million
revenue per share TTM
1.8$
valuation ratios | |
|---|---|
| pe ratio | 35.05 |
| peg ratio | 1.00 |
| price to book ratio | 6.13 |
| price to sales ratio | 18.71 |
| enterprise value multiple | 43.26 |
| price fair value | 6.13 |
profitability ratios | |
|---|---|
| gross profit margin | 68.78% |
| operating profit margin | 42.4% |
| pretax profit margin | 50.1% |
| net profit margin | 53.3% |
| return on assets | 16.04% |
| return on equity | 19.36% |
| return on capital employed | 13.77% |
liquidity ratios | |
|---|---|
| current ratio | 10.14 |
| quick ratio | 9.73 |
| cash ratio | 4.30 |
efficiency ratios | |
|---|---|
| days of inventory outstanding | 735.12 |
| operating cycle | 861.91 |
| days of payables outstanding | 40.96 |
| cash conversion cycle | 820.95 |
| receivables turnover | 2.88 |
| payables turnover | 8.91 |
| inventory turnover | 0.50 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.00 |
| debt equity ratio | 0.00 |
| long term debt to capitalization | 0.00 |
| total debt to capitalization | 0.00 |
| interest coverage | 0.00 |
| cash flow to debt ratio | 103.77 |
cash flow ratios | |
|---|---|
| free cash flow per share | 5.72 |
| cash per share | 25.25 |
| operating cash flow per share | 6.09 |
| free cash flow operating cash flow ratio | 0.94 |
| cash flow coverage ratios | 103.77 |
| short term coverage ratios | 103.77 |
| capital expenditure coverage ratio | 16.60 |
Frequently Asked Questions
When was the last time Krystal Biotech, Inc. (NASDAQ:KRYS) reported earnings?
Krystal Biotech, Inc. (KRYS) published its most recent earnings results on 03-11-2025.
What is Krystal Biotech, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Krystal Biotech, Inc. (NASDAQ:KRYS)'s trailing twelve months ROE is 19.36%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Krystal Biotech, Inc. (KRYS) currently has a ROA of 16.04%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did KRYS's net profit margin stand at?
KRYS reported a profit margin of 53.3% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is KRYS's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 10.14 in the most recent quarter. The quick ratio stood at 9.73, with a Debt/Eq ratio of 0.00.